SFX by Ex Libris Inc.

Title:	OPA1 functionally interacts with MIC60 but is dispensable for crista junction formation
Source:	Febs Letters [0014-5793] Barrera, Miguel yr:2016

Basic

Full text

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Krasnianski, A. "Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis." Brain 128.Pt 8 (2005): 1870-74.
description	2.	Mahad, D., D. "Review: Mitochondria and disease progression in multiple sclerosis." Neuropathology and applied neurobiology 34.6 (2008): 577-589.
description	3.	Stys, P K K. "Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger." The journal of neuroscience 12.2 (1992): 430-9.
description	4.	Vercellino, M. "Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study." Journal of neuroimmunology 199.1/2 (2008): 133-41.
description	5.	Correale, J. "The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting." Autoimmunity 40.2 (2007): 148-60.
description	6.	Lucchinetti, J. "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination." Annals of neurology 47.6 (2000): 707-17.
description	7.	Mahad, D., Ziabreva, I., Lassmann, H., Turnbull, D, D. "Mitochondrial defects in acute multiple sclerosis lesions." Brain 131.7 (2008): 1722-35.
description	8.	Lucchinetti, Claudia F F. "The immunopathology of multiple sclerosis: an overview." Brain pathology 17.2 (2007): 210-8.
description	9.	Prineas, John W W. "Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion." Annals of neurology 55.4 (2004): 458-68.
description	10.	Kooi, E. "Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications." Neurology 79.13 (2012): 1369-1376.
description	11.	Stys, Peter K K. "Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis." Lancet. Neurology 8.3 (2009): 280-91.
description	12.	Todorich, B. "Tim-2 is the receptor for H-ferritin on oligodendrocytes." Journal of neurochemistry 107.6 (2008): 1495-1505.
description	13.	Lassmann, H. "Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy." Trends in molecular medicine 7.3 (2001): 115-21.
description	14.	Trapp, Bruce D D. "Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients." Annals of neurology 59.3 (2006): 478-489.
description	15.	Stys, P K K. "Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics." Journal of cerebral blood flow and metabolism 18.1 (1997): 2-25.
description	16.	Lassmann, Hans E. "Cortical demyelination and diffuse white matter injury in multiple sclerosis." Brain 128.Part 11 (2005): 2705-12.
description	17.	Marfella R, Filippo CD, Laieta MT, Vestini R, Barb, R. "Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients." The journals of gerontology. Series A, Biological sciences and medical sciences 63.2 (2008): 200-203.
description	18.	Tsujino, A. "Myasthenic syndrome caused by mutation of the SCN4A sodium channel." Proceedings of the National Academy of Sciences of the United States of America 100.12 (2003): 7377-7382.
description	19.	Waxman, Stephen G G. "Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis." Trends in molecular medicine 12.5: 192-5.
description	20.	Fainardi, E. "Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting Multiple Sclerosis." Journal of Neuroimmunology 192.1/2 (2007): 219-225.